RNK-07421

N/A

Report date: 2023/09/28 16:17:49
NME

Base Information

Drug NameRNK-07421
Drug Alias NameRNK-07421RNK07421
ClassificationSmall molecules
Mechanisms of ActionKRAS G12C inhibitorsHeat shock protein HSP90 inhibitors
TargetsKRAS G12CHeat shock protein HSP90
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRanok Therapeutics (Hangzhou) Co LtdUniversity Of Illinois At Chicago
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Illinois At ChicagoRanok Therapeutics (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A